Abbott Molecular m2000 Viral Load Supplies

The Centers for Disease Control and Prevention (CDC) is seeking to award a firm-fixed price, sole source purchase order to Abbott Molecular, Inc. for the purchase of maintenance services for the Abbott m2000 RealTime PCR Platform. The platform is a fully-automated molecular system capable of performing FDA-approved tests for various diseases, including HIV-1, HCV, HBV, and CT/NG. The system includes unique specifications such as a single fully-automated molecular platform, a universal collection device for specimen collection and transportation, and a control strategy that requires only one set of controls regardless of batch size. • The Abbott m2000 RealTime PCR Platform is a fully-automated molecular system. • The platform is capable of performing FDA-approved tests for various diseases. • The system includes a universal collection device for specimen collection and transportation. • The control strategy requires only one set of controls regardless of batch size. • The system uses the maxRatio Data Analysis, which incorporates multiple validity checks for improved confidence in patient results.